EFTA01447223.txt Text dataset_10 View on DOJ

Illegal Activity

none

Blackmail

none

Date

2014-04-23

Document Type

financial_report

Model

gemini-2.0-flash-001

Processed

2026-02-07T18:42

Summary

This document is a financial report detailing stock holdings in various biotech companies as of April 23, 2014. It lists the quantity, current price, unit cost, market value, current total cost, and unrealized gain/loss for each stock.

Metadata

Subject: Stock Holdings
Sender: —
Recipients: —
Document ID: DB-SDNY-0101789 SDNY_GM_00247973
Date: 2014-04-23

Financial Information

Amounts:14.178.44708,500.00422,214.00286,286.00300.61119.55629,786.33250,454.95379,331.3826.7427.51668,500.00687,663.50(19,163.50)74.9379.41606,932.19643,204.00(36,271.81)7.5817.60125,333.65290,997.40(165,663.75)2,739,052.172,294,533.85444,518.32

Assets:

SANGAMO BIOSCIENCES
BIOGEN
FOUNDATION MEDICINE
GILEAD SCIENCES INC
ARIAD PHARMACEUTICALS

Raw Analysis JSON click to expand

Themes

Financial transactions/money flow

Organizations 5

SANGAMO BIOSCIENCESBIOGENFOUNDATION MEDICINEGILEAD SCIENCES INCARIAD PHARMACEUTICALS

Text Analysis

Tone: Informative
Purpose: To provide a snapshot of stock holdings and their performance as of a specific date.
Significance: The document details the market value, cost, and unrealized gains/losses for various biotech stocks.

File Info

File Name: EFTA01447223.txt
Dataset: dataset_10
Type: Text
Model: gemini-2.0-flash-001
Processed: 2026-02-07T18:42:04.248676
DOJ Source: View on DOJ